Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes.

Background: Local recurrence remains the major cause of death in patients with retroperitoneal sarcoma (RPS). There is no consensus regarding management of patients with recurrent RPS.

Study Design: We performed a retrospective review of patients with recurrent RPS managed at 2 tertiary care centers between 1983 and 2008.